Hypertension and gut microbial hydrogenases: a comparison of hydrogen metabolism and etiology
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
Human metagenomic analyses found distinct gut microbial hydrogenase patterns in hypertension, and Mendelian-randomization analysis associated greater hydrogen metabolism with lower hypertension risk. This is evidence about endogenous microbial hydrogen metabolism, not a trial of administered hydrogen therapy.
What the Findings Mean
The findings support an association between microbial hydrogen metabolism and blood-pressure regulation and suggest specific hydrogenase patterns as candidate biomarkers. They do not show that drinking or inhaling molecular hydrogen treats hypertension.
What the Researchers Studied
The study compared hydrogenase-expression patterns in public gut microbiome metagenomic data from people with hypertension and controls, adjusted for demographic and lifestyle factors, and added Mendelian-randomization analysis.
What Effects Did Molecular Hydrogen Have?
Compared with controls, the hypertension group showed a 2.3-fold increase in [FeFe] group A3 hydrogenases, a 55.6% decrease in [NiFe] group 1d hydrogenases, and other subtype differences. Mendelian-randomization analysis reported an odds ratio of 0.72 (95% CI 0.61–0.85; P<0.001) for hydrogen metabolism in relation to hypertension.
Why These Findings Matter
The findings support an association between microbial hydrogen metabolism and blood-pressure regulation and suggest specific hydrogenase patterns as candidate biomarkers. They do not show that drinking or inhaling molecular hydrogen treats hypertension.
How Strong Is This Evidence?
Human observational metagenomic analysis with Mendelian-randomization modeling. Stronger than a simple correlation, but not an administered-H2 intervention trial.
Technical Study Details
Model: Public human gut-metagenomic datasets comparing hypertension and control groups
Sample: Publicly available human metagenomic cohorts; exact total sample not stated in the abstract
DOI: 10.4103/mgr.MEDGASRES-D-25-00128
Limitations and Safety
Limitations: The study relies on existing microbiome datasets and genetic-instrument assumptions. Causal interpretation of Mendelian randomization depends on instrument validity, and the work does not test an H2 treatment dose.
Safety: No hydrogen therapy was administered, so treatment safety was not evaluated.
Original Study and H2HUBB Research Context
This publication is an exact-identity member of H2HUBB Gold v1.1.4. The materialized summary is bounded to the certified source evidence used for this import. Source basis: PubMed/PMC abstract. Original/source record.